George S. Barrett | Business Roundtable

Contact

  • General Inquiries
    202.872.1260
    info@brt.org
  • Mailing Address
    300 New Jersey Avenue, NW
    Suite 800
    Washington, D.C. 20001
  • Media Contact
    Betsy Andres Stewart
    Senior Director
    bstewart@brt.org

Membership Contact
LeAnne Redick Wilson
Senior Vice President
​lwilson@brt.org

    

What is Business Roundtable

Business Roundtable (BRT) is an association of chief executive officers of leading U.S. companies working to promote sound public policy and a thriving U.S. economy.

More Than Leaders. Leadership.

Business Roundtable is an association of chief executive officers of leading U.S. companies working to promote a thriving economy and expanded opportunity for all Americans through sound public policy.

About BRT

George S. Barrett is chairman and chief executive officer of Cardinal Health, a Fortune 20 health care services company dedicated to improving the cost-effectiveness of healthcare.

Barrett has refocused the company on enabling customers to improve the business behind health care, so pharmacies, hospitals and ambulatory care sites can focus on patient care, while reducing costs, improving efficiency and quality, and increasing profitability.

Barrett joined Cardinal Health in 2007 as vice chairman and chief executive officer of the company’s Healthcare Supply Chain Services segment, where he was responsible for all of Cardinal Health’s supply chain businesses, including pharmaceutical distribution, medical/surgical distribution, nuclear pharmacy services, Presource® surgical kitting services and the Medicine Shoppe International retail pharmacy franchise operations.

Previously, Mr. Barrett served as CEO of Teva North America and corporate executive vice president of Global Pharmaceutical Markets of Teva Pharmaceutical Industries Ltd. He held the position of president and CEO of Teva Pharmaceuticals USA from March 1999 to December 2004. Prior to joining Teva Pharmaceuticals in 1999, Mr. Barrett held various positions with Alpharma Inc., serving as president of US Pharmaceuticals from 1994 to 1997, and president of NMC Laboratories, prior to its acquisition by Alpharma in 1990.